BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Global X Lithium & Battery Tech ETF
LIT
$1.6B
| $939K | ﹤0.01% |
12,960
-24,068
| -65% | -$1.55M |
|
2102
Pacira BioSciences
PCRX
$924M
| $938K | ﹤0.01% |
15,463
+6,874
| +80% | +$435K |
|
2103
Minerals Technologies
MTX
$2.25B
| $938K | ﹤0.01% |
11,921
-9,785
| -45% | -$791K |
|
|
PRFT
2104
DELISTED
Perficient Inc
PRFT
| $937K | ﹤0.01% |
11,657
+4,983
| +75% | +$351K |
|
|
CSW
2105
CSW Industrials
CSW
$5.65B
| $936K | ﹤0.01% |
7,903
-1,365
| -15% | -$174K |
|
2106
Werner Enterprises
WERN
$2.31B
| $934K | ﹤0.01% |
20,979
+2,220
| +12% | +$104K |
|
2107
Eagle Bancorp
EGBN
$877M
| $933K | ﹤0.01% |
16,643
+635
| +4% | +$35.2K |
|
2108
CALL
US Bancorp
USB
$101B
| $929K | ﹤0.01% |
+163
| New | +$9.56K |
|
2109
NETGEAR
NTGR
$658M
| $927K | ﹤0.01% |
24,191
+2,084
| +9% | +$80.8K |
|
2110
Methode Electronics
MEI
$602M
| $925K | ﹤0.01% |
18,806
+813
| +5% | +$37.9K |
|
2111
National Fuel Gas
NFG
$7.77B
| $923K | ﹤0.01% |
17,670
+2,468
| +16% | +$128K |
|
|
KW
2112
DELISTED
Kennedy-Wilson Holdings
KW
| $923K | ﹤0.01% |
46,457
-44,741
| -49% | -$904K |
|
2113
J&J Snack Foods
JJSF
$1.7B
| $922K | ﹤0.01% |
5,286
-1,464
| -22% | -$247K |
|
|
BPY
2114
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $919K | ﹤0.01% |
48,511
-11,788
| -20% | -$215K |
|
2115
Shenandoah Telecom
SHEN
$721M
| $919K | ﹤0.01% |
18,939
-5,039
| -21% | -$250K |
|
2116
Fossil Group
FOSL
$330M
| $917K | ﹤0.01% |
64,224
+30,886
| +93% | +$407K |
|
2117
CALL
Dollar Tree
DLTR
$24.7B
| $915K | ﹤0.01% |
92
| – | – |
|
|
EMBJ
2118
Embraer S.A. ADS
EMBJ
$13.2B
| $911K | ﹤0.01% |
60,192
+5,423
| +10% | +$70.1K |
|
2119
Acadia Pharmaceuticals
ACAD
$5.07B
| $910K | ﹤0.01% |
37,293
+11,809
| +46% | +$267K |
|
2120
Piper Sandler
PIPR
$5.34B
| $910K | ﹤0.01% |
28,080
-6,988
| -20% | -$214K |
|
2121
CALL
Nektar Therapeutics
NKTR
$2.57B
| $909K | ﹤0.01% |
+35
| New | +$9.69K |
|
2122
Aaon
AAON
$7.23B
| $909K | ﹤0.01% |
21,794
+9,512
| +77% | +$419K |
|
2123
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
| $909K | ﹤0.01% |
+15,000
| New | +$896K |
|
2124
Corcept Therapeutics
CORT
$12.1B
| $908K | ﹤0.01% |
41,288
+9,286
| +29% | +$207K |
|
2125
International Bancshares
IBOC
$4.52B
| $908K | ﹤0.01% |
21,145
-8,675
| -29% | -$405K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.